Histological investigation of veins and venous malformations after injection of sclerosing agents

Asian Journal of Oral and Maxillofacial Surgery

Volumn 14, Issue 4, 2002, Pages 226-231

  Zhao, Ji Hong ^a   Zhao, Yi Fang ^a   Chen, Xing Ming ^a   Zheng, Xiang ^a   Zhang, Wen Fen ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Sodium morrhuate; Veins; Venous malformations

Indexed keywords

BLEOMYCIN A5; MORRHUATE SODIUM; SCLEROSING AGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL WALL; CELL SWELLING; CELL VACUOLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INJECTION PAIN; INTIMA; NONHUMAN; OBSERVATION; OCCLUSION; PATHOLOGICAL ANATOMY; RABBIT; SCLEROTHERAPY; STENOSIS; THROMBOGENESIS; VEIN MALFORMATION;

EID: 0036453049     PISSN: 09156992     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0915-6992(02)80008-5     Document Type: Article

References (12)

1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-422.
2. Glowacki J, Mulliken JB. Mast cells in hemangiomas and vascular malformations. Pediatrics 1982; 70:48-51.
3. Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: Complications and results. Plast Reconstr Surg 1999;104:1-11.
4. Pappas DC Jr, Persky MS, Berenstein A. Evaluation and treatment of head and neck venous vascular malformations. Ear Nose Throat J 1998; 77:914-916.
5. Rebeiz E, April MM, Bohigian RK, Shapshay SM. Nd-YAG laser treatment of venous malformations of the head and neck: An update. Otolaryngol Head Neck Surg 1991;105:655-661.
6. Dubois JM, Sebag GH, DeProst Y, Teillac D, Chertien B, Brunelle FD. Soft tissue venous malformations in children: Percutaneous sclerotherapy with ethibloc. Radiology 1991;180:195-198.
7. Persky MS, Berenstein A, Cohen NL. Combined treatment of head and neck vascular masses with preoperative embolization. Laryngoscope 1984;94:20-27.
8. Yakes WF, Luethke JM, Parker SH, Stavros AT, Rak KM, Hopper KD, Dreisbach JN, Griffin DJ, Seibert CE, Carter TE, et al. Ethanol embolization of vascular malformations. Radiographics 1990;10:787-796.
9. Tai KW, Chang YC, Chou LS, Chou MY. Cytotoxic effect of pingyangmycin on cultured KB cells. Oral Oncol 1998;34:219-223.
10. Jia MY, Jin ZQ, Tan YS, Fan GW, Shang W. Treatment of maxillofacial cavernous hemangioma with pingyangmycin [article in Chinese]. Zhonghue Kou Qing Yi Xue Za Zhi 1994;29:294-295.
11. Nicolson GL, Custead SE. Effects of chemotherapeutic drugs on platelet and metastatic tumor cell-endothelial cell interactions as a model for assessing vascular endothelial integrity. Cancer Res 1985;45:331-336.
12. Okada A, Kubota A, Fukuzawa M, Imura K, Kamatas S. Injection of bleomycin as a primary therapy of cystic lymphangioma. J Pediatr Surg 1992;27:440-443.